 
| IPAD-DB ID | S00024 | 
| Name | Methacycline hydrochloride | 
| Category | Synthetic compounds | 
| 2D Structure |  | 
| 3D Structure | |
| Molecular Formula | C 2 2 H 2 3 C l N 2 O 8 | 
| Molecular Weight | 478.9g/mol | 
| IUPAC Name | (4S, 4aR, 5S, 5aR, 12aR)-4-(dimethylamino)-1, 5, 10, 11, 12a-pentahydroxy-6-methylidene-3, 12-dioxo-4, 4a, 5, 5a-tetrahydrotetracene-2-carboxamide;hydrochloride | 
| InChI | InChI=1S/C22H22N2O8.ClH/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14, 32)19(12)29;/h4-6, 10, 14-15, 17, 25-27, 30, 32H, 1H2, 2-3H3, (H2, 23, 31);1H/t10-, 14-, 15+, 17+, 22+;/m1./s1 | 
| InChIKey | VXPSARQTYDZXAO-CCHMMTNSSA-N | 
| Canonical SMILES | CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O.Cl | 
| PubChem CID | 54685047 | 
| DrugBank Accession Number | - | 
| CAS Registry Number | - | 
| Molecular Weight(Computed by SwissADME) | 478.88 | 
| Hac(Computed by SwissADME) | 33 | 
| Volume(Computed by ADMETlab 2.0) | 423.43 | 
| Density(Computed by ADMETlab 2.0) | 1.044 | 
| nRing(Computed by ADMETlab 2.0) | 4 | 
| MaxRing(Computed by ADMETlab 2.0) | 18 | 
| nHet(Computed by ADMETlab 2.0) | 10 | 
| fChar(Computed by ADMETlab 2.0) | 0 | 
| nRig(Computed by ADMETlab 2.0) | 27 | 
| Flexibility(Computed by ADMETlab 2.0) | 0.074 | 
| Stero Centers(Computed by ADMETlab 2.0) | 7 | 
| LogS(Computed by ADMETlab 2.0) | -1.091 | 
| LogD(Computed by ADMETlab 2.0) | -0.107 | 
| logP(Computed by ADMETlab 2.0) | 0.022 | 
| TPSA(Computed by SwissADME) | 181.62 | 
| Hbond Acceptor(Computed by SwissADME) | 9 | 
| Hbond Donor(Computed by SwissADME) | 6 | 
| Rotatable Bonds(Computed by SwissADME) | 2 | 
| GI Absorption(Computed by SwissADME) | Low | 
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No | 
| P-gp Substrate(Computed by SwissADME) | Yes | 
| CYP1A2 Inhibitor(Computed by SwissADME) | No | 
| CYP2C19 Inhibitor(Computed by SwissADME) | No | 
| CYP2C9 Inhibitor(Computed by SwissADME) | No | 
| CYP2D6 Inhibitor(Computed by SwissADME) | No | 
| CYP3A4 Inhibitor(Computed by SwissADME) | No | 
| log Kp(Skin Permeation)(Computed by SwissADME) | -8.43 | 
| Lipinski(Computed by SwissADME) | 1 | 
| Ghose(Computed by SwissADME) | 0 | 
| Veber(Computed by SwissADME) | 1 | 
| Egan(Computed by SwissADME) | 1 | 
| Muegge(Computed by SwissADME) | 2 | 
| Bioavailability Score(Computed by SwissADME) | 0.11 |